Skip to main content
. 2021 May 5;12(3):586–598. doi: 10.1002/jcsm.12705

Table 2.

Risk factors for probable sarcopenia in individuals with CKD

Sarcopenic (n = 844) Non‐sarcopenic (n = 7890) P value
Age, years 63.9 (4.5) 62.7 (5.9) <0.001
Sex, male, n (%) 364 (43%) 3678 (47%) 0.058
Ethnicity
White 769 (91%) 7549 (96%) <0.001
Other 75 (9%) 341 (4%)
No. of comorbidities
0 84 (10%) 1887 (24%) <0.001
1 238 (28%) 2695 (34%)
2 227 (27%) 1932 (24%)
≥3 295 (35%) 1376 (17%)
Albumin, g/L 43.4 (3.2) 44.5 (2.8) <0.001
CRP, mg/L a 2.9 (1.3–6.2) 1.9 (1.0–3.9) <0.001
Testosterone, nmol/L a 4.3 (1.0–10.0) 6.1 (1.0–10.9) 0.015
HbA1c, mmol/L a 41.5 (12.0) 39.0 (8.7) <0.001
Cystatin C, mg/L 1.5 (0.5) 1.3 (0.4) <0.001
BMI, kg/m2 29.8 (5.8) 29.2 (5.1) 0.012
Vitamin D (nmol/L) 46.8 (23.0) 50.1 (22.1) <0.001
IGF‐1 (nmol/L) 41.5 (12.0) 39.0 (8.7) 0.008
Haemoglobin, g/dL 13.2 (1.5) 13.9 (1.4) <0.001
No. of weekly meat servings 7.3 (3.2) 7.5 (2.9) 0.048
METs exercise a 74.3 (00.0–433.1) 272.8 (37.1–810.0) <0.001

BMI, body mass index; CKD, chronic kidney disease; CRP, C‐reactive protein; IGF, insulin‐like growth factor; METs, metabolic equivalent of task.

a

Median and interquartile range.

Data presented as mean and standard deviation, unless otherwise indicated.

Missing data for these variables can be found in Table S8.